Oncternal Therapeutics Probability of Future Stock Price Finishing Over 0.0

Oncternal Therapeutics' future price is the expected price of Oncternal Therapeutics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Oncternal Therapeutics performance during a given time horizon utilizing its historical volatility. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
  
Please specify Oncternal Therapeutics' target price for which you would like Oncternal Therapeutics odds to be computed.

Oncternal Therapeutics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Oncternal Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Oncternal Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Oncternal Therapeutics is not yet fully synchronised with the market data
Oncternal Therapeutics has some characteristics of a very speculative penny stock
Oncternal Therapeutics has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 785 K. Net Loss for the year was (39.48 M) with loss before overhead, payroll, taxes, and interest of (31.49 M).
Oncternal Therapeutics currently holds about 78.9 M in cash with (32.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.48.

Oncternal Therapeutics Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Oncternal Stock often depends not only on the future outlook of the current and potential Oncternal Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Oncternal Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding2.9 M
Cash And Short Term Investments34.3 M

Oncternal Therapeutics Technical Analysis

Oncternal Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Oncternal Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Oncternal Therapeutics. In general, you should focus on analyzing Oncternal Stock price patterns and their correlations with different microeconomic environments and drivers.

Oncternal Therapeutics Predictive Forecast Models

Oncternal Therapeutics' time-series forecasting models is one of many Oncternal Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Oncternal Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Oncternal Therapeutics

Checking the ongoing alerts about Oncternal Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Oncternal Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Oncternal Therapeutics is not yet fully synchronised with the market data
Oncternal Therapeutics has some characteristics of a very speculative penny stock
Oncternal Therapeutics has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 785 K. Net Loss for the year was (39.48 M) with loss before overhead, payroll, taxes, and interest of (31.49 M).
Oncternal Therapeutics currently holds about 78.9 M in cash with (32.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.48.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Consideration for investing in Oncternal Stock

If you are still planning to invest in Oncternal Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oncternal Therapeutics' history and understand the potential risks before investing.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios